Portola Investor Cries Foul Over Tender Offer Math
Portola Pharmaceuticals Inc. and its chief executive and board were hit Tuesday with a shareholder action in New York federal court accusing the company of filing opaque financial analyses with the...To view the full article, register now.
Already a subscriber? Click here to view full article